pfizer - Search News

Pfizer CEO had dinner with RFK Jr.

Hosted on MSN · 10h

Pfizer's CEO says he's had dinner with Trump's health secretary pick, RFK Jr.

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's "radical" changes.

Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines

Pfizer shares rose early Tuesday due to higher than expected demand for its COVID vaccine, but quickly sunk 2.3% after Kennedy was confirmed.

RFK Jr. 'tempered' his stance on vaccines in private discussions, Pfizer CEO says

Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health sector.

Pfizer's Retail Traders Cheer Better-Than-Expected Q4

Pfizer beats profit estimates on cost cuts, COVID vaccine sales

Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine. Francis Maguire reports. US says will levy tariffs on Mexico, Canada and China on Feb. 1

Pfizer beats Q4, FY '24 earnings estimates, stock flat in premarket trading

Pfizer ( PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and sending the stock up about 1% in premarket trading.

Newsable Asianet News on MSN · 1d

Pfizer's Retail Traders Cheer Better-Than-Expected Q4 Even As Stock Dips: ‘Another Beat And Still Crazy Cheap'

Shares of Pfizer Inc. (PFE) slipped nearly 1.5% on Tuesday afternoon, even as the pharmaceutical giant posted a stronger-than-expected fourth-quarter report that energized retail traders. Pfizer reported adjusted earnings per share (EPS) of $0.

1hon MSN

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

1d

Pfizer shows profit growth from cost cuts and steadier COVID sales

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Crain's New York1d

Pfizer gets unexpected boost from Covid vaccine and pill

Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...

1d

Pfizer’s Covid Boost Overshadowed by Kennedy Threat to Vaccines

Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...

1d

Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing

With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as ...

1d

PFE Earnings: Pfizer Stock Jumps on Q4 Beats

Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company ...

BioPharma Dive2d

Pfizer drug acquired in $11B buyout confirms benefit in colon cancer

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results